The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R) PK11195 PET imaging and neuropathology study

Z Su, F Roncaroli, PF Durrenberger… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The 18-kDa mitochondrial translocator protein (TSPO) is upregulated in high-grade
astrocytomas and can be imaged by PET using the selective radiotracer 11C-(R) PK11195 …

The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside

K Janczar, Z Su, I Raccagni, A Anfosso… - Biochemical Society …, 2015 - portlandpress.com
The 18-kDa mitochondrial translocator protein (TSPO) is known to be highly expressed in
several types of cancer, including gliomas, whereas expression in normal brain is low. TSPO …

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

NL Albert, M Unterrainer, DF Fleischmann… - European journal of …, 2017 - Springer
Objective The 18-kDa mitochondrial translocator protein (TSPO) was reported to be
upregulated in gliomas. 18 F-GE-180 is a novel 3rd generation TSPO receptor ligand with …

TSPO as a target for glioblastoma therapeutics

EL Werry, ML Barron, M Kassiou - Biochemical Society …, 2015 - portlandpress.com
The translocator protein (TSPO) is an 18-kDa five-transmembrane protein, which is primarily
found in the outer mitochondrial membrane. Levels of this protein are up-regulated in the …

TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma

Y Fu, D Wang, H Wang, M Cai, C Li, X Zhang… - Neuro …, 2020 - academic.oup.com
Background The ligands of mitochondrial translocator protein (TSPO) have been widely
used as diagnostic biomarkers for glioma. However, the true biological actions of TSPO in …

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma

NL Albert, DV Nelwan, DF Fleischmann… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The 18-kDa translocator protein (TSPO) is gaining recognition as a relevant target in
glioblastoma imaging. However, data on the potential prognostic value of TSPO PET …

The translocator protein (TSPO): a novel target for cancer chemotherapy

CJD Austin, J Kahlert, M Kassiou… - The international journal of …, 2013 - Elsevier
The translocator protein (TSPO) is an 18kDa transmembrane protein primarily found in the
outer mitochondrial membrane where it forms a key part of the mitochondrial permeability …

[HTML][HTML] Classical and novel TSPO ligands for the mitochondrial TSPO can modulate nuclear gene expression: implications for mitochondrial retrograde signaling

N Yasin, L Veenman, S Singh, M Azrad, J Bode… - International Journal of …, 2017 - mdpi.com
It is known that knockdown of the mitochondrial 18 kDa translocator protein (TSPO) as well
as TSPO ligands modulate various functions, including functions related to cancer. To study …

Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies

J Tong, B Williams, PM Rusjan… - Journal of Cerebral …, 2020 - journals.sagepub.com
Positron emission tomography (PET) imaging of the translocator protein (TSPO) is widely
used as a biomarker of microglial activation. However, TSPO protein concentration in human …

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

M Unterrainer, DF Fleischmann, F Vettermann… - European journal of …, 2020 - Springer
Background The 18-kDa translocator protein (TSPO) is overexpressed in brain tumours and
represents an interesting target for glioma imaging. 18 F-GE-180, a novel TSPO ligand, has …